Precise subunit ratios in cardiac ion channels are not an accident of random assembly — they are actively enforced during protein biogenesis, and understanding how that control works has direct implications for inherited arrhythmia syndromes and drug-channel interactions that underlie dangerous QT prolongation.
The hERG (human Ether-à-go-go Related Gene) potassium channel is the molecular backbone of the cardiac rapid delayed rectifier current (IKr), which is indispensable for normal repolarization of the ventricular action potential. The channel can be formed by two subunit variants — hERG1a and hERG1b — and this new work published in PNAS establishes that their heteromeric assembly is not stochastic. Using biochemical and functional analyses, the investigators demonstrate that a specific endoplasmic reticulum (ER) retention motif embedded in one of the subunits acts as a gating mechanism during channel biogenesis, enforcing a fixed 2:2 stoichiometry. Without this quality-control signal, assembly ratios drift, altering the channel's biophysical fingerprint in ways that could reshape repolarization kinetics.
This finding fits into a growing appreciation that cellular protein quality-control machinery does far more than eliminate misfolded proteins — it actively sculpts the molecular composition of functional complexes. For the cardiac repolarization field, the implications are notable: hERG1a and hERG1b channels have distinct kinetics, pharmacology, and drug-binding sensitivity, meaning the stoichiometric ratio is a functional variable, not merely a structural footnote. If mutations or environmental stressors perturb the ER retention motif, the resulting shift in subunit ratio could mimic a loss-of-function state and predispose to Long QT syndrome without altering channel protein levels. The study is mechanistic and primarily molecular in scope, so translational distance to the clinic remains significant — but it reframes how researchers should think about channel channelopathy genetics and drug safety screening.